Phosphoinositide 3-Kinase Signaling in the Tumor Microenvironment: What Do We Need to Consider When Treating Chronic Lymphocytic Leukemia With PI3K Inhibitors?

por Aydin, Ebru, Faehling, Sebastian, Saleh, Mariam, Llaó Cid, Laura, Seiffert, Martina, Roessner, Philipp M.
Publicado 2021

New approach methodologies to facilitate and improve the hazard assessment of non-genotoxic carcinogens—a PARC project

por Audebert, Marc, Assmann, Ann-Sophie, Azqueta, Amaya, Babica, Pavel, Benfenati, Emilio, Bortoli, Sylvie, Bouwman, Peter, Braeuning, Albert, Burgdorf, Tanja, Coumoul, Xavier, Debizet, Kloé, Dusinska, Maria, Ertych, Norman, Fahrer, Jörg, Fetz, Verena, Le Hégarat, Ludovic, López de Cerain, Adela, Heusinkveld, Harm J., Hogeveen, Kevin, Jacobs, Miriam N., Luijten, Mirjam, Raitano, Giuseppa, Recoules, Cynthia, Rundén-Pran, Elise, Saleh, Mariam, Sovadinová, Iva, Stampar, Martina, Thibol, Lea, Tomkiewicz, Céline, Vettorazzi, Ariane, Van de Water, Bob, El Yamani, Naouale, Zegura, Bojana, Oelgeschläger, Michael
Publicado 2023